Assuming the data still blinded you would be a weirdly foolish CEO to comment as above unless there was significant difference between the 2 groups in the trial. Odd not to comment or maybe not asked if the 350 number has been met?
Group 1 following the typical path of standard treatment which is a known and making up approx 50% of the number
Group 2 significantly different result compared to group one . Obviously exceeded even ACL trial design expectations?
How pissed off should shareholders be that we can't get a reply call from anyone at ACL and a 2 bit media gets a scoop ( whether they understand the significance or not) like above if the quote is correct as someone as experienced as TL shouldn't get the reading of presumably blinded data wrong or comment unless there was a very significant obvious difference between the 2 groups. yes something odd could be happening but since we are comparing to a known treatment with many trials that statistic is pretty well known.
I wonder when TL made those quotes?
If the data is already locked and they haven't announced it it is very disappointing .
If the data is already locked and TL is commenting on initial unblinded data I would be stunned, shocked , horrified that he would comment to a 2 bit local paper and not do it on ASX announcement if it is quoted correctly above. If it is not quoted correct lf above at this late stage ASX announcement should be done to correct the article. Allowing media at this late stage to publish quotes not a whole media statement is pretty bad form IMO as it is what is around those words that can change the meaning. Clear ASX announcements in plain English should be the only thing coming from ACL office outlining timing and process going forward in a bit more detail as we aren't all bio rocket scientists who know process like the back of our hands and the brokers are pretty average at telling holders. .
Was sort of happy with the silence as unless the detail in the article is verified as a valid quote in correct context it is more what you expect from a small wild west mining company not from what will be a very prospective successful small bio about to verify a breakthrough platform..
- Forums
- ASX - By Stock
- Alchemia’s make-or-break moment arrives with late-stage cancer drug
Assuming the data still blinded you would be a weirdly foolish...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable